AUS
NZ
UK
CA
USA
IND
Growthpoint Properties Australia (ASX:GOZ) has sought the Quotation of 181,456 fully paid ordinary stapled securities on the ASX, following the conversion of deferred short-term incentive (STI) performance rights granted under its FY24 and FY25 employee incentive schemes. These securities were issued on 30 June 2026 without any cash payment from the holders, in line with the terms of the deferred STI plans. Included in this conversion were 48,356 performance rights held by key management personnel, notably Chief Executive Ross Lees, via an associated entity. This transaction increases Growthpoint's total quoted stapled securities to 754,608,746, while several classes of unquoted performance rights remain outstanding.
Key Points
- Company: Growthpoint Properties Australia (ASX:GOZ)
- Conversion of 181,456 GOZAC STI performance rights into fully paid ordinary stapled securities (GOZ) on 30 June 2026
- Rights vested under FY24 (Tranche 2) and FY25 (Tranche 1) deferred STI employee incentive plans with no cash consideration payable
- VWAP reference prices used for grant calculations were $2.18 and $2.39 per stapled security respectively
- Key management personnel involvement: Ross Lees converted 48,356 performance rights through Elgin1906 Pty Ltd ATF Lees Family A/C
- Total quoted GOZ stapled securities after this issue: 754,608,746
- Outstanding unquoted performance rights include 4,009,399 LTI rights (GOZAA), 124,482 (GOZAJ), and 121,065 STI rights (GOZAC)
Issuance of 181,456 GOZ Stapled Securities Following Performance Rights Vesting on 30 June 2026
On 1 July 2026, Growthpoint Properties Australia filed an Appendix 2A with the ASX requesting quotation of 181,456 fully paid ordinary stapled securities. These securities were issued on 30 June 2026 through the conversion of GOZAC-class performance rights categorized as short-term incentive (STI) rights under the company’s employee incentive framework.
This conversion transitioned rights from an unquoted class (GOZAC) into the existing quoted class (GOZ), representing Growthpoint’s fully paid ordinary stapled securities. The newly issued securities rank equally with existing quoted securities from their Issue Date, entitling holders to identical distributions, voting rights, and other benefits from 30 June 2026 onward.
Conversion Driven by FY24 Tranche 2 and FY25 Tranche 1 Deferred STI Plans
The vested and converted performance rights originated from two tranches of Growthpoint’s deferred STI incentive programs. The FY24 Tranche 2 plan applied a ten-trading-day Volume weighted average price (VWAP) of $2.18 per stapled security at grant, while the FY25 Tranche 1 plan used a VWAP reference of $2.39 per stapled security. These VWAP figures determined the number of performance rights granted rather than a conversion price.
Recipients paid no cash consideration upon vesting. The company confirmed the consideration for these securities was nil, consistent with typical deferred Equity remuneration structures where value is embedded in the rights themselves, avoiding cash outlays at conversion. This method is common among ASX-listed real estate Investment trusts and diversified property groups to align management incentives with long-term securityholder interests.
Ross Lees Converts 48,356 Performance Rights via Associated Entity
The update reveals that key management personnel participated in the conversion. Ross Lees, a member of Growthpoint’s key management team, converted 48,356 GOZAC STI performance rights through an associated entity, Elgin1906 Pty Ltd ATF Lees Family A/C, rather than in his personal name.
Disclosure of key management personnel involvement is mandatory in Appendix 2A filings when such individuals or their associates hold converting securities. Conversion through associated entities complies with ASX Listing Rules provided full disclosure is made. The remaining 133,100 converted performance rights in this batch belong to other plan participants, though no further recipient details were provided.
Growthpoint’s Quoted Stapled Securities Total 754,608,746 Post-Issue
Following the quotation of these 181,456 new stapled securities, Growthpoint’s total quoted security count rose to 754,608,746 GOZ stapled securities. This figure is generated by ASX systems during the Appendix 2A process and may not fully reflect the current Capital/">Issued Capital if other filings are concurrently processed.
The issued securities represent a very small portion of the overall capital base, resulting in minimal dilution for existing securityholders. This issuance reflects ongoing equity-based remuneration activity. Growthpoint has not indicated any changes to its distribution policy, Earnings guidance, or strategic direction related to this issuance.
Outstanding Performance Rights in GOZAC, GOZAA, and GOZAJ Classes
After this conversion, Growthpoint’s unquoted securities register still holds significant performance rights across three classes. The GOZAA class, representing long-term incentive (LTI) rights, has 4,009,399 securities outstanding. The GOZAJ class retains 124,482 rights, and the GOZAC STI class now has 121,065 rights remaining following the conversion of 181,456.
The presence of these unquoted rights indicates potential future conversions as additional tranches vest. Investors concerned about dilution or remuneration structure should monitor the conversion schedule, especially for the large GOZAA LTI pool. Vesting timelines for remaining rights were not disclosed.
No Cash Proceeds Received by Growthpoint From This Issuance
Since the performance rights were granted as deferred compensation under the FY24 and FY25 STI plans, Growthpoint received no cash inflow from their conversion into stapled securities. The consideration per security was zero, reflecting standard treatment of employee equity plan vesting events. This differs from capital raises, Placements, or other fund-raising securities issuances.
The absence of cash proceeds means no direct impact on Growthpoint’s Balance Sheet Liquidity or its ability to finance property acquisitions, Capital Expenditure, or Debt repayments. The event mainly serves remuneration transparency and accurate securities counting, important for analyst models and institutional investor evaluations of governance and equity structure.
Role of Deferred STI Plans in Growthpoint’s Remuneration Strategy
Deferred short-term incentive plans reward employees and executives for performance in a given financial year but defer equity delivery over time. This retention mechanism aligns recipients’ interests with securityholders, as the rights’ value depends on Growthpoint’s security price at grant and during the Holding Period.
Growthpoint’s FY24 and FY25 STI plans each included multiple tranches, with FY25 Tranche 1 and FY24 Tranche 2 vesting simultaneously on 30 June 2026. Such staggered vesting is typical among Australian listed companies, allowing multiple prior-year tranches to vest concurrently. No forward vesting schedule was provided.
Implications for GOZ Securityholders of Performance Rights Conversions
For Growthpoint securityholders, periodic conversion of performance rights into stapled securities is a routine but significant event. While this conversion of 181,456 securities against a base exceeding 754 million is not materially dilutive, cumulative vesting across GOZAA, GOZAJ, and GOZAC classes could increase the securities count meaningfully over time.
The immediate share price impact was unclear from available information. Investors focusing on Growthpoint’s property portfolio, distribution Yield, and net Tangible Asset backing will likely regard this conversion as a routine matter rather than a strategic or financial shift. Future key dates include additional Appendix 2A filings for vesting tranches and forthcoming financial or distribution announcements.
About Growthpoint Properties Australia and Its ASX Listing
Growthpoint Properties Australia is an ASX-listed stapled security group trading under ticker GOZ, comprising Growthpoint Properties Australia Trust (ARSN 120 121 002) and Growthpoint Properties Australia Limited (ABN 33 124 093 901). It is an internally managed real estate investment trust focused on Australian office and industrial properties. Each GOZ unit represents combined interests in both the trust and company, with distributions sourced from both.
The use of stapled securities in employee incentive plans aligns with the company’s structure, granting recipients economic exposure to the property portfolio rather than simple corporate shares. With the total quoted stapled securities now at 754,608,746, Growthpoint’s Capital Structure remains largely stable from a Market Capitalisation perspective, though exact market cap depends on prevailing GOZ security prices.
